Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiao-Shan Wang, Yi-Feng Bai, Vivek Verma, Rui-Lian Yu, Wei Tian, Rui Ao, Ying Deng, Xue-Qiang Zhu, Hao Liu, Hai-Xia Pan, Lan Yang, Han-Song Bai, Xing Luo, Yan Guo, Ming-Xiu Zhou, Yue-Mei Sun, Zi-Can Zhang, Si-Min Li, Xue Cheng, Bang-Xian Tan, Liang-Fu Han, Ying-Yi Liu, Kai Zhang, Fan-Xin Zeng, Lin Jia, Xin-Bao Hao, You-Yu Wang, Gang Feng, Ke Xie, You Lu, Ming Zeng

Open source

DOI: 10.1093/jnci/djac015
Published: 2022-01-30
Container: JNCI: Journal of the National Cancer Institute
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

limited evidence Score 46/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djac015,
  title = {Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer},
  author = {Xiao-Shan Wang and Yi-Feng Bai and Vivek Verma and Rui-Lian Yu and Wei Tian and Rui Ao and Ying Deng and Xue-Qiang Zhu and Hao Liu and Hai-Xia Pan and Lan Yang and Han-Song Bai and Xing Luo and Yan Guo and Ming-Xiu Zhou and Yue-Mei Sun and Zi-Can Zhang and Si-Min Li and Xue Cheng and Bang-Xian Tan and Liang-Fu Han and Ying-Yi Liu and Kai Zhang and Fan-Xin Zeng and Lin Jia and Xin-Bao Hao and You-Yu Wang and Gang Feng and Ke Xie and You Lu and Ming Zeng},
  year = {2022},
  journal = {JNCI: Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djac015},
  url = {https://doi.org/10.1093/jnci/djac015}
}

RIS

TY  - JOUR
TI  - Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
AU  - Xiao-Shan Wang
AU  - Yi-Feng Bai
AU  - Vivek Verma
AU  - Rui-Lian Yu
AU  - Wei Tian
AU  - Rui Ao
AU  - Ying Deng
AU  - Xue-Qiang Zhu
AU  - Hao Liu
AU  - Hai-Xia Pan
AU  - Lan Yang
AU  - Han-Song Bai
AU  - Xing Luo
AU  - Yan Guo
AU  - Ming-Xiu Zhou
AU  - Yue-Mei Sun
AU  - Zi-Can Zhang
AU  - Si-Min Li
AU  - Xue Cheng
AU  - Bang-Xian Tan
AU  - Liang-Fu Han
AU  - Ying-Yi Liu
AU  - Kai Zhang
AU  - Fan-Xin Zeng
AU  - Lin Jia
AU  - Xin-Bao Hao
AU  - You-Yu Wang
AU  - Gang Feng
AU  - Ke Xie
AU  - You Lu
AU  - Ming Zeng
PY  - 2022
JO  - JNCI: Journal of the National Cancer Institute
DO  - 10.1093/jnci/djac015
UR  - https://doi.org/10.1093/jnci/djac015
ER  -

APA

Wang, X., Bai, Y., Verma, V., Yu, R., Tian, W., Ao, R., Deng, Y., Zhu, X., Liu, H., Pan, H., Yang, L., Bai, H., Luo, X., Guo, Y., Zhou, M., Sun, Y., Zhang, Z., Li, S., Cheng, X., Tan, B., Han, L., Liu, Y., Zhang, K., Zeng, F., Jia, L., Hao, X., Wang, Y., Feng, G., Xie, K., Lu, Y., & Zeng, M. (2022). Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djac015

Source records

crossref · retrieved 2026-09-25T20:44:48.976Z